Structure of Dihydroquinidine CAS 1435-55-8

Dihydroquinidine CAS 1435-55-8

/in , , /by

Identification

CAS Number

1435-55-8

Name

Dihydroquinidine

Synonyms

(+)-Dihydroquinidine
(9S)-10,11-Dihydro-6′-methoxycinchonan-9-ol
(9S)-6′-Methoxy-10,11-dihydrocinchonan-9-ol [ACD/IUPAC Name]
(9S)-6′-Methoxy-10,11-dihydrocinchonan-9-ol [German] [ACD/IUPAC Name]
(9S)-6′-Méthoxy-10,11-dihydrocinchonan-9-ol [French] [ACD/IUPAC Name]
1435-55-8 [RN]
215-862-5 [EINECS]
216-024-1 [EINECS]
8P68XPY4HG
91441
Cinchonan-9-ol, 10,11-dihydro-6′-methoxy-, (9S)- [ACD/Index Name]
dihydroquinidine [Wiki]
hydroconchinine
hydroquinidine
MFCD00135599 [MDL number]
MX3016000
(+)-Hydroquinidine
(1S)-((2R,4S,5R)-5-Ethylquinuclidin-2-yl)(6-methoxyquinolin-4-yl)methanol
(S)-((1S,2R,4S,5R)-5-Ethylquinuclidin-2-yl)(6-methoxyquinolin-4-yl)methanol
(S)-[(2R,4S,5R)-5-ethyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol
[1435-55-8]
10,11-dihydro-6′-methoxy-cinchonan-9S-ol
10,11-Dihydroquinidine
1030-06-4 [RN]
Chlorambucil sodium salt
Cinchonan-9-ol, 10,11-dihydro-6′-methoxy-, (9S)- (9CI)
DIHYDRO QUINIDINE
Dihydroquinidine;(+)-Hydroquinidine;Hydroconquinine
GNF-PF-2067
Hydroconquinine
hydroquinidine 95%
hydroquinidine 95%(contains of ethanol)
hydroquinidine anhydrous
hydroquinidineanhydrous
UNII:8P68XPY4HG
Untitled Document

SMILES

CC[[email protected]]1CN2CC[[email protected]]1C[C@@H]2[[email protected]](c3ccnc4c3cc(cc4)OC)O

StdInChI

InChI=1S/C20H26N2O2/c1-3-13-12-22-9-7-14(13)10-19(22)20(23)16-6-8-21-18-5-4-15(24-2)11-17(16)18/h4-6,8,11,13-14,19-20,23H,3,7,9-10,12H2,1-2H3/t13-,14-,19+,20-/m0/s1

StdInChIKey

LJOQGZACKSYWCH-LHHVKLHASA-N

Molecular Formula

C20H26N2O2

Molecular Weight

326.433

MDL Number

MFCD00135599

Properties

Appearance

White to off-white solid

Safety Data

WGK Germany

3

Specifications and Other Information of Our Dihydroquinidine CAS 1435-55-8

Identification Methods

HNMR, HPLC

Purity

99% min

Shelf Life

2 years

Storage

-20°C Freezer, Under inert atmosphere

Known Application

It can be used as organic synthesis intermediates and pharmaceutical intermediates, and is an antiarrhythmic drug.eutical intermediates.

This product is developed by our R&D company Caming Pharmaceutical Ltd (https://www.caming.com/).

This product is developed by our R&D company Watson International Ltd (https://www.watson-int.com/).